ANT CL International Insurance (ACL) 0.295 0.00

ANT CL INTL INSUR
(ACL) 0.295 0.00

Last Trade:	0.155	Day Range:	0.155 - 0.155
Trade Time:	07:02AM	52wk Range:	0.15 - 0.32
Prev. Close:	0.155	Market Cap:	1.59M
Open:	0.00	Div Yield:
Volume:	0	PE:
EPS:	-0.06

The Latest On ACL

Novartis International AG: Novartis Completes Merger With Alcon, Required Total Of 165M Shares Instead Of 215M (ACL) 4/8/11 9:04am

Alcon Shareholders Approve Merger with Novartis (ACL) 4/7/11 3:17pm

LifeTech Capital Comments On Merck Acquisition (MRK, ISPH) 4/7/11 7:42am

Piper Jaffray Discontinues Coverage on Alcon (ACL) 3/17/11 7:26am

Puts Purchased on Alcon, Inc. (ACL) 3/11/11 12:34pm

Protection Bought on Alcon, Inc. (ACL) 2/23/11 10:52am

Vaccines Pull Down NVS Q4 Earnings - Analyst Blog 1/28/11 10:31am

Vaccines Pull Down NVS Q4 Earnings - Analyst Blog 1/28/11 10:15am

Novartis to Buy Genoptix - Analyst Blog 1/28/11 8:40am

Novartis to Buy Genoptix - Analyst Blog 1/28/11 8:15am

Alcon's Winning Streak Continues - Analyst Blog 1/27/11 12:01pm

Alcon's Winning Streak Continues - Analyst Blog 1/27/11 11:30am

Novartis International AG: Novartis Completes Merger With Alcon, Required Total Of 165M Shares Instead Of 215M (ACL) 4/8/11

Alcon Shareholders Approve Merger with Novartis (ACL) 4/7/11

LifeTech Capital Comments On Merck Acquisition (MRK, ISPH) 4/7/11

Piper Jaffray Discontinues Coverage on Alcon (ACL) 3/17/11

Puts Purchased on Alcon, Inc. (ACL) 3/11/11

Protection Bought on Alcon, Inc. (ACL) 2/23/11

Vaccines Pull Down NVS Q4 Earnings - Analyst Blog 1/28/11

Novartis to Buy Genoptix - Analyst Blog 1/28/11

Alcon's Winning Streak Continues - Analyst Blog 1/27/11

Puts Purchased on Alcon, Inc. (ACL) 3/11/11

Protection Bought on Alcon, Inc. (ACL) 2/23/11

Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Dividend Yield (BAX, BDX, COV, ACL) 1/10/11

Puts Purchased on Alcon, Inc. (ACL) 12/21/10

A Peek Into The Market Before The Trading Starts 12/15/10

US Stock Futures Down As Investors Await Economic Data 12/15/10

Stocks To Watch For October 5 (YUM, ACL, WWW, MOS, DMND) 10/5/10

Very Important Positions to Hedge Funds (AAPL, BIDU, CIT, QQQ, JPM, INTC, QCOM, XRX) 6/8/10

Top 5 Large-Cap NYSE Stocks In The Healthcare Sector With The Highest Return On Equity (GSK, LLY, AZN, ACL, NVO) 6/7/10

Karen Finerman Sees An Opportunity In ACL, ARG, SII, GGP 5/24/10

Benzinga’s Top Upgrades (FSLR, RIG, C, PEG, ACL) 5/24/10

Alcon May Receive Improved Offer From NVS Soon 5/21/10

LifeTech Capital Comments On Merck Acquisition (MRK, ISPH) 4/7/11

Piper Jaffray Discontinues Coverage on Alcon (ACL) 3/17/11

Citigroup Downgrades Alcon To Hold 1/20/11

A Peek Into The Market Before The Trading Starts 12/15/10

Collins Stewart Says Buy Alcon (ACL) 11/9/10

Jefferies & Company Raises Alcon Estimates 10/22/10

Benzinga's Top Downgrades (STX, DEG, LZB, ACL) 10/21/10

Alcon Reports "High Quality" EPS Beat 10/21/10

3Q Upside For Medical Tech. & Hospital Supplies 10/14/10

ACL, JNJ Beating 3Q Estimates 9/30/10

Alcon, Inc.Acquires LenSx, Still In Negotiations With Novartis (ACL, NVS) 7/7/10

Industry Update On Medical Technology & Hospital Supplies (ACL, JNJ) 6/17/10

Trade ACL
NOW!

Partner Headlines

Challenging Labor Economics in the Coal Industry 10/26/11

Wright Medical Gets a New CEO - Analyst Blog 9/20/11

Novartis Profit Falls 4%, Sales Rise 16% 4/19/11

NVS Amends sNDA; Completes Merger - Analyst Blog 4/11/11

Alcon Shareholders Approve Merger - Analyst Blog 4/8/11

Novartis Drug Approval Delayed - Analyst Blog 3/25/11

NVS' Lucentis Gets EU Backing - Analyst Blog 3/23/11

Novartis' Gilenya Approved in EU - Analyst Blog 3/22/11

Mixed Opinion on NVS Lung Drug - Analyst Blog 3/10/11

4 Best Holdings in Harvard's Portfolio 3/10/11

Alcon, Inc. - Growth & Income 2/24/11

5 Drug Stocks With Upside Potential of 25% 1/20/11

Press Releases

New Study Shows Partial Knee Replacements Increasing and a Better Bet for Some, says Santa Cruz Orthopaedic Institute 2/7/12 PRWeb Story

Huntington Bancshares Incorporated Reports $126.9 Million of Net Income, or $0.14 Per Common Share, for the 2011 Fourth Quarter, Down 12% from the Prior Quarter and up 3% from the Year-Ago Quarter; Declares Quarterly Dividend... 1/19/12 Business Wire Story

Former Competitive Skier Turned Doctor is Available to Talk About Avoiding Ski and Snowboarding Injuries 1/12/12 Business Wire Story

Texas Mother to Honor Sons' Lives during the Rose Bowl Parade 12/19/11 Business Wire Story

Professor Hans H. Paessler to Present at Inaugural Emerging Techniques in Orthopedics Conference, December 8 in Las Vegas 12/6/11 Business Wire Story

BMO Reports Fourth Quarter Results, Finishing a Good Year With Net Income of $3.3 Billion for Fiscal 2011 12/6/11 Marketwire Story

A.M. Best Affirms Ratings of CIGNA Corporation and Its Subsidiaries 12/2/11 Business Wire Story

Austin City Limits Rings in 2012 with Special Performance by Coldplay in First-Ever New Year's Eve Episode 12/1/11 PRWeb Story

Geoscape Solar Helps Make a Greener New Jersey in the City of Elizabeth and Creates Green Jobs 11/30/11 PRWeb Story

Radisys Announces Ultra-High Capacity Network Search Solution for Deep Packet Inspection in Next Generation Wireless Infrastructure 10/31/11 Business Wire Story

Get the latest ACL stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for ANT CL INTL INSUR stock price.

ANT CL INTL INSUR by YCharts

ANT CL International Insurance (ACL) 0.295 0.00

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On ACL

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social